相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii
Elias Dahdouh et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial
J. Nowak et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Diversity of polymyxin resistance mechanisms among Acinetobacter baumannii clinical isolates
Raquel Girardello et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2017)
Interplay between Colistin Resistance, Virulence and Fitness in Acinetobacter baumannii
Gabriela Jorge Da Silva et al.
ANTIBIOTICS-BASEL (2017)
Impaired growth under iron-limiting conditions associated with the acquisition of colistin resistance in Acinetobacter baumannii
Rafael Lopez-Rojas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
The Effect of Colistin Resistance-Associated Mutations on the Fitness of Acinetobacter baumannii
Xinli Mu et al.
FRONTIERS IN MICROBIOLOGY (2016)
Global metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumannii
Mohd Hafidz Mahamad Maifiah et al.
SCIENTIFIC REPORTS (2016)
Biofilm Formation and Motility Depend on the nature of the Acinetobacter baumannii clinical isolates
Saranya Vijayakumar et al.
FRONTIERS IN PUBLIC HEALTH (2016)
Emergence of colistin resistance without loss of fitness and virulence after prolonged colistin administration in a patient with extensively drug-resistant Acinetobacter baumannii
Emanuele Durante-Mangoni et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2015)
Genetic basis of antimicrobial resistance and clonal dynamics of carbapenem-resistant Acinetobacter baumannii sequence type 191 in a Korean hospital
Gati Noble Selasi et al.
INFECTION GENETICS AND EVOLUTION (2015)
Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii
Meritxell Garcia-Quintanilla et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Growth Retardation, Reduced Invasiveness, and Impaired Colistin-Mediated Cell Death Associated with Colistin Resistance Development in Acinetobacter baumannii
Spyros Pournaras et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Biological Cost of Different Mechanisms of Colistin Resistance and Their Impact on Virulence in Acinetobacter baumannii
Alejandro Beceiro et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Activity of Host Antimicrobials against Multidrug-Resistant Acinetobacter baumannii Acquiring Colistin Resistance through Loss of Lipopolysaccharide
Meritxell Garcia-Quintanilla et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Metal limitation and toxicity at the interface between host and pathogen
Kyle W. Becker et al.
FEMS MICROBIOLOGY REVIEWS (2014)
Colistin Resistance in a Clinical Acinetobacter baumannii Strain Appearing after Colistin Treatment: Effect on Virulence and Bacterial Fitness
Rafael Lopez-Rojas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
On the essentiality of lipopolysaccharide to Gram-negative bacteria
Ge Zhang et al.
CURRENT OPINION IN MICROBIOLOGY (2013)
In vitro activity of 18 antimicrobial agents against clinical isolates of Acinetobacter spp.: multicenter national study GEIH-REIPI-Ab 2010
Felipe Fernandez-Cuenca et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2013)
Genomic insights into the fate of colistin resistance and Acinetobacter baumannii during patient treatment
Evan S. Snitkin et al.
GENOME RESEARCH (2013)
Lipopolysaccharide-Deficient Acinetobacter baumannii Shows Altered Signaling through Host Toll-Like Receptors and Increased Susceptibility to the Host Antimicrobial Peptide LL-37
Jennifer H. Moffatt et al.
INFECTION AND IMMUNITY (2013)
Emergence of Colistin-Resistance in Extremely Drug-Resistant Acinetobacter baumannii Containing a Novel pmrCAB Operon During Colistin Therapy of Wound Infections
Emil Lesho et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models
Michael J. McConnell et al.
FEMS MICROBIOLOGY REVIEWS (2013)
Colistin-Resistant, Lipopolysaccharide-Deficient Acinetobacter baumannii Responds to Lipopolysaccharide Loss through Increased Expression of Genes Involved in the Synthesis and Transport of Lipoproteins, Phospholipids, and Poly-beta-1,6-N-Acetylglucosamine
Rebekah Henry et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Colistin: an update on the antibiotic of the 21st century
Silpak Biswas et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2012)
Insertion Sequence ISAba11 Is Involved in Colistin Resistance and Loss of Lipopolysaccharide in Acinetobacter baumannii
Jennifer H. Moffatt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Phosphoethanolamine Modification of Lipid A in Colistin-Resistant Variants of Acinetobacter baumannii Mediated by the pmrAB Two-Component Regulatory System
Alejandro Beceiro et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Vaccination with Outer Membrane Complexes Elicits Rapid Protective Immunity to Multidrug-Resistant Acinetobacter baumannii
Michael J. McConnell et al.
INFECTION AND IMMUNITY (2011)
Impaired Virulence and In Vivo Fitness of Colistin-Resistant Acinetobacter baumannii
Rafael Lopez-Rojas et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production
Jennifer H. Moffatt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine
Michael J. McConnell et al.
VACCINE (2010)
Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System
Mark D. Adams et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Regulation of Acinetobacter baumannii biofilm formation
Jennifer A. Gaddy et al.
FUTURE MICROBIOLOGY (2009)
Nosocomial Outbreak of Infection With Pan-Drug-Resistant Acinetobacter baumannii in a Tertiary Care University Hospital
Raquel Valencia et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
The cost of resistance to colistin in Acinetobacter baumannii: a proteomic perspective
Maria Fernandez-Reyes et al.
PROTEOMICS (2009)
Successful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including tigecycline
F. S. Taccone et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2006)
Moraxella catarrhalis bacterium without endotoxin, a potential vaccine candidate
DX Peng et al.
INFECTION AND IMMUNITY (2005)
Molecular basis of bacterial outer membrane permeability revisited
H Nikaido
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2003)
Biofilms: Survival mechanisms of clinically relevant microorganisms
RM Donlan et al.
CLINICAL MICROBIOLOGY REVIEWS (2002)
分享论文
